BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, May 8, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 19, 2006
View Archived Issues
Neuroprotective effects of a component of the perineuronal net
Read More
Intravail increases intranasal bioavailability in first clinical study
Read More
ConjuChem places DAC:GRF program in HIV lipodystrophy on clinical hold
Read More
Memory achieves preclinical milestones in Roche collaboration
Read More
Lpath first to generate functional antibodies against LPA
Read More
Fast track designation for intravenous methylnaltrexone in postoperative ileus
Read More
BioProgress completes acquisition of Segix Farma
Read More
BioLineRx inlicenses orally available peptide for treatment of obesity
Read More
Positive results for PT-502 in animal model for antidepressant activity
Read More
Enzo cleared for phase II study of EGS-21 in NASH
Read More
Crucell suspends further development of Aerugen
Read More
Enrollment under way in phase I study of INNO-406 in leukemias
Read More
BioDelivery Sciences submits Emezine study plans to FDA
Read More
TH-070 fails to meet endpoint in BPH phase II and phase III trials
Read More
Cimzia shows potential in psoriasis
Read More
GM-CSF enhances immune response to melanoma vaccine Vaccimel
Read More
Analyses point to mycophenolate mofetil efficacy in lupus nephritis
Read More
CNRS present new data on BACE1 inhibition by JMV-2764
Read More
Zelapar for Parkinson's disease now available
Read More
GSK profile GSK-189254 at ICAD meeting
Read More
Chemically programmed antibodies: a potential new class of antitumor agents
Read More
New dopamine D3 receptor antagonist shows antipsychotic activity lacking D2-related side effects
Read More
Positive in vitro safety profile of beta-secretase inhibitors from LG Life Sciences
Read More
New therapeutic strategies for cancer imparted in recent patents
Read More
Antiglaucoma agents revealed by French researchers
Read More
Agents for wound healing and pruritus described
Read More